Antiallergic effects of Vitis amurensis on mast cell-mediated allergy model

Experimental Biology and Medicine

Volumn 233, Issue 2, 2008, Pages 192-199

  Kim, Sang Hyun ^a   Taeg, Kyu Kwon ^b   Shin, Tae Yong ^c  

^a Kyungpook National University School of Medicine   (South Korea)

^b Keimyung University   (South Korea)

^c Woosuk University   (South Korea)

Author keywords

Allergic reaction; Histamine; Mast cells; Proinflammatory cytokines; Vitis amurensis

Indexed keywords

ANTIALLERGIC AGENT; CALCIMYCIN; CALCIUM ION; COMPOUND 48-80; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; METHANOL; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VITIS AMURENSIS EXTRACT;

ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG MECHANISM; GRAPE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMEDIATE TYPE HYPERSENSITIVITY; MALE; MAST CELL; MOUSE; NONHUMAN; PASSIVE SKIN ANAPHYLAXIS; RAT; VITIS AMURENSIS;

ANIMALS; ANTI-ALLERGIC AGENTS; CALCIUM; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; HISTAMINE RELEASE; HYPERSENSITIVITY; IMMUNOGLOBULIN E; MALE; MAST CELLS; MICE; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PASSIVE CUTANEOUS ANAPHYLAXIS; PLANT EXTRACTS; RATS; VITIS;

MUS; VITACEAE; VITIS AMURENSIS;

EID: 38949110340     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0708-RM-222     Document Type: Article

References (33)

1. Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 110:341-348, 2002.
2. Metzger H, Alcaraz G, Hohman R, Kinet JP, Pribluda V, Quarto R. The receptor with high affinity for immunoglobulin E. Annu Rev Immunol 4:419-470, 1986.
3. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23:749-786, 2005.
4. Petersen LJ, Mosbech H, Skov PS. Allergen-induced histamine release in intact human skin in vivo assessed by skin microdialysis technique: characterization of factors influencing histamine releasability. J Allergy Clin Immunol 97:672-679, 1996.
5. Galli SJ, Gordon JR, Wershil BK. Cytokine production by mast cells and basophils. Curr Opin Immunol 3:865-872, 1991.
6. Azzolina A, Bongiovanni A, Lampiasi N. Substance P induces TNF-alpha and IL-6 production through NF kappa B in peritoneal mast cells. Biochim Biophys Acta 1643:75-83, 2003.
7. Kim SH, Jun CD, Suk K, Choi BJ, Lim H, Park S, Lee SH, Shin HY, Kim DK, Shin TY. Gallic acid inhibits histamine release and proinflammatory cytokine production in mast cells. Toxicol Sci 91:123-131, 2006.
8. Shin TY, Kim SH, Suk K, Ha JH, Kim I, Lee MG, Jun CD, Kim SY, Lim JP, Eun JS, Shin HY, Kim HM. Anti-allergic effects of Lycopus lucidus on mast cell-mediated allergy model. Toxicol Appl Pharmacol 209:255-262, 2005.
9. Guo JX, Kimura T, But PPH, Sung CK, Han BH. International Collation of Traditional and Folk Medicine. Singapore: World Scientific, pp661-662, 2001.
10. Wang JN, Chen YJ, Hano Y, Nomura T, Tan RX. Antioxidant activity of polyphenols from seeds of Vitis amurensis in vitro. Acta Pharmacol Sin 21:633-636, 2000.
11. Huang KS, Lin M. Oligostilbenes from the roots of Vitis amurensis. J Asian Nat Prod Res 2:21-28, 1999.
12. Jang MH, Piao XL, Kim HY, Cho EJ, Baek SH, Kwon SW, Park JH. Resveratrol oligomers from Vitis amurensis attenuate beta-amyloid-induced oxidative stress in PC12 cells. Biol Pharm Bull 30:1130-1134, 2007.
13. Huang KS, Lin M, Cheng GF. Anti-inflammatory tetramers of resveratrol from the roots of Vitis amurensis and the conformations of the seven-membered ring in some oligostilbenes. Phytochemistry 58: 357-362, 2001.
14. Lee EO, Lee HJ, Hwang HS, Ahn KS, Chae C, Kang KS, Lu J, Kim SH. Potent inhibition of Lewis lung cancer growth by heyneanol A from the roots of Vitis amurensis through apoptotic and anti-angiogenic activities. Carcinogenesis 27:2059-2069, 2006.
15. Kim SH, Choi CH, Kim SY, Eun JS, Shin TY. Anti-allergic effects of Artemisia iwayomogi on mast cell-mediated allergy model. Exp Biol Med (Maywood) 230:82-88, 2005.
16. Kim SH, Shin TY. Effect of Dracocephalum argunense on mast-cell-mediated hypersensitivity. Int Arch Allergy Immunol 139:87-95, 2006.
17. Lee DH, Kim SH, Eun JS, Shin TY. Mosla dianthera inhibits mast cell-mediated allergic reactions through the inhibition of histamine release and inflammatory cytokine production. Toxicol Appl Pharmacol 216:479-484, 2006.
18. Kim SH, Johnson VJ, Sharma RP. Mercury inhibits nitric oxide production but activates proinflammatory cytokine expression in murine macrophage: differential modulation of NF-kappaB and p38 MAPK signaling pathways. Nitric Oxide 7:67-74, 2002.
19. Beaven MA, Metzger H. Signal transduction by Fc receptors: the Fc epsilon RI case. Immunol Today 14:222-226, 1993.
20. Sillaber C, Bevec D, Butterfield JH, Heppner C, Valenta R, Scheiner O, Kraft D, Lechner K, Bettelheim P, Valent P. Tumor necrosis factor alpha and interleukin-1 beta mRNA expression in HMC-1 cells: differential regulation of gene product expression by recombinant interleukin-4. Exp Hematol 21:1271-1275, 1993.
21. Arbabi S, Maier RV. Mitogen-activated protein kinases. Crit Care Med 30:S74-S79, 2002.
22. Beyaert R, Cuenda A, Vanden Berghe W, Plaisance S, Lee JC, Haegeman G, Cohen P, Fiers W. The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J 15:1914-1923, 1996.
23. Beaven MA, Rogers J, Moore JP, Hesketh TR, Smith GA, Metcalfe JC. The mechanism of the calcium signal and correlation with histamine release in 2H3 cells. J Biol Chem 259:7129-7136, 1984.
24. Alfonso A, Cabado AG, Vieytes MR, Botana LM. Functional compartments in rat mast cells for cAMP and calcium on histamine release. Cell Signal 12:343-350, 2000.
25. Mousli M, Bronner C, Bockaert J, Rouot B, Landry Y. Interaction of substance P, compound 48/80 and mastoparan with the alpha-subunit C-terminus of G protein. Immunol Lett 25:355-357, 1990.
26. Moller A, Henz BM, Grutzkau A, Lippert U, Aragane Y, Schwarz T, Kruger-Krasagakes S. Comparative cytokine gene expression: regulation and release by human mast cells. Immunology 93:289-295, 1998.
27. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci U S A 88:4220-4224, 1991.
28. Mican JA, Arora N, Burd PR, Metcalfe DD. Passive cutaneous anaphylaxis in mouse skin is associated with local accumulation of interleukin-6 mRNA and immunoreactive interleukin-6 protein. J Allergy Clin Immunol 90:815-824, 1992.
29. Sengupta B, Banerjee A, Sengupta PK. Investigations on the binding and antioxidant properties of the plant flavonoid fisetin in model biomembranes. FEBS Lett 570:77-81, 2004.
30. Jeong HJ, Hong SH, Lee DJ, Park JH, Kim KS, Kim HM. Role of Ca(2+) on TNF-alpha and IL-6 secretion from RBL-2H3 mast cells. Cell Signal 14:633-639, 2002.
31. Manthey CL, Wang SW, Kinney SD, Yao Z. SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes. J Leukoc Biol 64:409-417, 1998.
32. Shapiro L, Dinarello CA. Osmotic regulation of cytokine synthesis in vitro. Proc Natl Acad Sci U S A 92:12230-12234, 1995.
33. Collart MA, Baeuerle P, Vassalli P. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol Cell Biol 10:1498-1506, 1990.